IIT2020-20-SHIRAZIP-WALK: Nature Walks
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Thyroid Cancer
Related studies linked through entity extraction aliases.
Salivary dysfuncTion After Radioiodine Treatment
- Status
- COMPLETED
- Phase
- N/A
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy.
- Status
- UNKNOWN
- Phase
- NA
Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance
- Status
- COMPLETED
- Phase
- N/A
Energy Metabolism in Thyroidectomized Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TH1902 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Laser Ablation of Papillary Thyroid Microcarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA
- Status
- COMPLETED
- Phase
- N/A
Circulating Biomarkers to Identify Thyroid Cancer
- Status
- COMPLETED
- Phase
- N/A
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation
- Status
- UNKNOWN
- Phase
- NA
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study
- Status
- UNKNOWN
- Phase
- PHASE2
Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A